Abstract
Physicians involved in cancer pain management treat thousands of patients with opioids, whose effective analgesia improves overall functioning. Side effects generally are tolerable, and treatment can be maintained with stable doses for long periods. Problems with addiction are infrequent. Many physicians, however, assume that opioids should be used only for chronic malignant pain. Research and clinical experience have demonstrated that opioids can safely and effectively relieve most chronic moderate to severe nonmalignant pain. Fears of addiction, disciplinary action, and adverse effects result in ineffective pain management. With current information on the use of opioids in chronic nonmalignant pain, primary care physicians can overcome these obstacles. Guidelines must clearly define the role of the primary care physician in the proper management of pain and the integration of opioid therapy. Used appropriately, opioids may represent the only source of relief for many patients.
Similar content being viewed by others
References
World Health Organization Expert Committee.Cancer Pain Relief and Palliative Care. WHO Technical Report Series. Geneva, Switzerland: WHO; 1990.
Bernabei R, Gambassi G, Lapane K, et al, for the SAGE Study Group. Management of pain in elderly patients with cancer.JAMA. 1998;279:1877–1882.
Moulin DE, Iezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain.Lancet. 1996;347:143–147.
Schug SA, Merry AF, Acland RH. Treatment principles for the use of opioids in pain of nonmalignant origin.Drugs. 1991;42:228–239.
Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain.J Pain Symptom Manage. 1992;7:69–77.
Dellemijn PLI, van Duijn H, Vanneste JAL. Prolonged treatment with transdermal fentanyl in neuropathic pain.J Pain Symptom Manage. 1998;16:220–229.
Passik SD, Portenoy RK. Substance abuse issues in palliative care. In: Berger A, ed.Principles and Practices of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998:chap 38.
Stacey BR. Effective management of chronic pain: the analgesic dilemma.Postgrad Med. 1996;100:281–293.
Weissman DE, Haddox JD. Opioid pseudoaddiction—an iatrogenic syndrome.Pain. 1989;36:363–366.
Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and “problematic” substance use: evaluation of a pilot assessment tool.J Pain Symptom Manage. 1998;16:355–363.
Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues.J Pain Symptom Manage. 1996;11:203–217.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Rinaldi RC, Steindler EM, Wilford BB, Goodwin D. Clarification and standardization of substance abuse terminology.JAMA. 1988;259:555–557.
Joranson DE, Gilson AM, Ryan KM, Maurer MA, Nelson JM.Achieving Balance in State Pain Policy: A Guide to Evaluation, Part I. Madison: Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center; 1999.
California Pain Statute. Business and Professions Code §2241.5(b) (1990).
Wilder-Smith CH. Pain treatment in multimorbid patients, the older population and other high-risk groups: the clinical challenge of reducing toxicity.Drug Saf. 1998;18:457–472.
Elliott TE. Pain control at the end of life.Minn Med. 1997;80:27–32.
Portenoy RK. Management of common opioid side effects during long-term therapy of cancer pain.Ann Acad Med Singapore. 1994;23:160–170.
Skaer TL. Management of pain in the cancer patient.Clin Ther. 1993;15:638–649.
Cherny NI, Portenoy RK. Cancer pain management: current strategy.Cancer. 1993;72(11 suppl):3393–3415.
Porter J, Jick H. Addiction rare in patients treated with narcotics.N Engl J Med. 1980;302:123. Letter.
Reidenberg MM, Portenoy RK. The need for an open mind about the treatment of chronic nonmalignant pain.Clin Pharmacol Ther. 1994;55:367–369.
Ahmedzai S, Brooks D, on behalf of the TTS-Fentanyl Comparative Trial Group. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life.J Pain Symptom Manage. 1997;13:254–261.
Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases.J Pain Symptom Manage. 1996;11:163–171.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Passik, S.D., Weinreb, H.J. Managing chronic nonmalignant pain: Overcoming obstacles to the use of opioids. Adv Therapy 17, 70–83 (2000). https://doi.org/10.1007/BF02854840
Issue Date:
DOI: https://doi.org/10.1007/BF02854840